Evidence map›Paper›PMID 29491644›Full record

ArticlePharmacognosy magazine2018

Mechanistic

Saba Feyzmand, Behzad Shahbazi, Marzieh Marami, Gholamreza Bahrami, Ali Fattahi, Yalda Shokoohinia

Open access · greenAbstract read
In one paragraph

Article in Pharmacognosy magazine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Antioxidant and Anti-atherogenic Properties ofFrontiers in physiology · 2021
    Article
  2. Antidiabetic Potential ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Saba FeyzmandStudent Research Committee, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Behzad ShahbaziPharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Marzieh MaramiPharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Gholamreza BahramiMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Ali FattahiMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Yalda ShokoohiniaPharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Kermanshah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMATERIALS AND

methodsSix different extracts of

resultsCytotoxicity study indicated that extracts were safe on β-TC

conclusionThe present study demonstrates that only INF extract have an antidiabetic potential by attenuating the death and apoptosis induced by STZ in β-TC SUMMARY: Six different extracts from

Indexed as

diabetes mellitushepatocellular carcinoma cell lineProsopis farctaβ-TC3 cells

Identifiers

PMID29491644
PMCPMC5822511
OpenAlexW2795795335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.